A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study (English)
- New search for: Santoro, A.
- New search for: Gebbia, V.
- New search for: Pressiani, T.
- New search for: Testa, A.
- New search for: Personeni, N.
- New search for: Arrivas Bajardi, E.
- New search for: Foa, P.
- New search for: Buonadonna, A.
- New search for: Bencardino, K.
- New search for: Barone, C.
- New search for: Santoro, A.
- New search for: Gebbia, V.
- New search for: Pressiani, T.
- New search for: Testa, A.
- New search for: Personeni, N.
- New search for: Arrivas Bajardi, E.
- New search for: Foa, P.
- New search for: Buonadonna, A.
- New search for: Bencardino, K.
- New search for: Barone, C.
In:
ANNALS OF ONCOLOGY
;
26
, 3
;
542-547
;
2015
-
ISSN:
- Article (Journal) / Print
-
Title:A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study
-
Contributors:Santoro, A. ( author ) / Gebbia, V. ( author ) / Pressiani, T. ( author ) / Testa, A. ( author ) / Personeni, N. ( author ) / Arrivas Bajardi, E. ( author ) / Foa, P. ( author ) / Buonadonna, A. ( author ) / Bencardino, K. ( author ) / Barone, C. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 26, 3 ; 542-547
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2015-01-01
-
Size:6 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 26, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 447
-
The failure of figitumumab: the danger of taking shortcuts in drug developmentWest, H. et al. | 2015
- 448
-
Nit-Picking around second line in EGFRwt NSCLC: just an academic effortLandi, L. / Cappuzzo, F. et al. | 2015
- 463
-
Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013Papamichael, D. / Audisio, R. A. / Glimelius, B. / de Gramont, A. / Glynne-Jones, R. / Haller, D. / K�hne, C. H. / Rostoft, S. / Lemmens, V. / Mitry, E. et al. | 2015
- 497
-
Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancerScagliotti, G. V. / Bondarenko, I. / Blackhall, F. / Barlesi, F. / Hsia, T. C. / Jassem, J. / Milanowski, J. / Popat, S. / Sanchez-Torres, J. M. / Novello, S. et al. | 2015
- 504
-
Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIAN2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapyLi, N. / Zeng, Z. F. / Wang, S. Y. / Ou, W. / Ye, X. / Li, J. / He, X. H. / Zhang, B. B. / Yang, H. / Sun, H. B. et al. | 2015
- 510
-
Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patientsMostert, B. / Sieuwerts, A. M. / Kraan, J. / Bolt-de Vries, J. / van der Spoel, P. / van Galen, A. / Peeters, D. J. / Dirix, L. Y. / Seynaeve, C. M. / Jager, A. et al. | 2015
- 517
-
Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancersLi, J. / Holm, J. / Bergh, J. / Eriksson, M. / Darabi, H. / Lindstr�m, L. S. / T�rnberg, S. / Hall, P. / Czene, K. et al. | 2015
- 523
-
Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancerWang, C. / Zhang, J. / Wang, Y. / Ouyang, T. / Li, J. / Wang, T. / Fan, Z. / Fan, T. / Lin, B. / Xie, Y. et al. | 2015
- 529
-
Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) surveyBelkacemi, Y. / Kaidar-Person, O. / Poortmans, P. / Ozsahin, M. / Valli, M. C. / Russell, N. / Kunkler, I. / Hermans, J. / Kuten, A. / van Tienhoven, G. et al. | 2015
- 535
-
Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancerSotelo, M. J. / Sastre, J. / Maestro, M. L. / Veganzones, S. / Vi�itez, J. M. / Alonso, V. / Gr�valos, C. / Escudero, P. / Vera, R. / Aranda, E. et al. | 2015
- 542
-
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh studySantoro, A. / Gebbia, V. / Pressiani, T. / Testa, A. / Personeni, N. / Arrivas Bajardi, E. / Foa, P. / Buonadonna, A. / Bencardino, K. / Barone, C. et al. | 2015
- 548
-
EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?Hong, J. Y. / Yoon, D. H. / Suh, C. / Huh, J. / Do, I. G. / Sohn, I. / Jo, J. / Jung, S. H. / Hong, M. E. / Yoon, H. et al. | 2015
- 556
-
A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancerJimeno, A. / Shirai, K. / Choi, M. / Laskin, J. / Kochenderfer, M. / Spira, A. / Cline-Burkhardt, V. / Winquist, E. / Hausman, D. / Walker, L. et al. | 2015
- 561
-
TEMHEAD: a single-arm multicentre phase II study of temsirolimus in platin- and cetuximab refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) of the German SCCHN Group (AIO)Gr�nwald, V. / Keilholz, U. / Boehm, A. / Guntinas-Lichius, O. / Hennemann, B. / Schmoll, H. J. / Ivanyi, P. / Abbas, M. / Lehmann, U. / Koch, A. et al. | 2015
- 567
-
Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005)Ferrari, A. / De Salvo, G. L. / Brennan, B. / van Noesel, M. M. / De Paoli, A. / Casanova, M. / Francotte, N. / Kelsey, A. / Alaggio, R. / Oberlin, O. et al. | 2015
- 573
-
A multicenter DeCOG study on predictors of vemurafenib therapy outcome in melanoma: pretreatment impacts survivalUgurel, S. / Loquai, C. / K�hler, K. / Hassel, J. / Berking, C. / Zimmer, L. / Haubitz, I. / Satzger, I. / M�ller-Brenne, T. / Mikhaimer, N. C. et al. | 2015
- 582
-
Impact of centralization on aCGH-based genomic profiles for precision medicine in oncologyCommo, F. / Fert�, C. / Soria, J. C. / Friend, S. H. / Andr�, F. / Guinney, J. et al. | 2015
- 589
-
Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysisPetridou, E. T. / Sergentanis, T. N. / Perlepe, C. / Papathoma, P. / Tsilimidos, G. / Kontogeorgi, E. / Kourti, M. / Baka, M. / Moschovi, M. / Polychronopoulou, S. et al. | 2015
- 598
-
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II studySch�ffski, P. / Besse, B. / Gauler, T. / de Jonge, M. J. / Scambia, G. / Santoro, A. / Davite, C. / Jannuzzo, M. G. / Petroccione, A. / Delord, J. P. et al. | 2015
- 608
-
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphomaa long-term follow-up studyKasenda, B. / Schorb, E. / Fritsch, K. / Finke, J. / Illerhaus, G. et al. | 2015